Somany Ceramics (531548) Q1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 25/26 earnings summary
7 Sep, 2026Executive summary
Q1 FY26 saw muted demand and pricing pressure, but sales grew 4.4% YoY (3% by volume), with Nepal sales contributing 1.2% but not consolidated due to local laws.
Focus on cost optimization, operational efficiency, and leveraging expanded product portfolio and distribution network.
Government housing and infrastructure initiatives are expected to support gradual demand recovery.
Net profit for Q1 was Rs. 735 lakhs (consolidated), down from Rs. 1,226 lakhs YoY.
Acquisition of 51% equity in Dura Build Care Private Limited completed in July 2025, making it a subsidiary.
Financial highlights
Consolidated sales grew 4.4% YoY to ₹601 crore in Q1; standalone sales up 3.6% YoY to ₹580 crore.
Operating margin at 8.0% for Q1; EBITDA margin improved to 6.1% standalone; gross margin rose 3.2% QoQ but fell 1.8% YoY.
PAT for FY25 at ₹58 crore, down 41.7% YoY; Q1 PAT at ₹10 crore; EPS at ₹14.65 for FY25 and ₹2.53 for Q1.
Standalone capacity utilization was 72%, consolidated dropped from 81% to 77%; tiles production at 10.57 msm in Q1.
Sanitaryware and bath fittings revenue was INR 63 crore, up from INR 61 crore; faucets grew from INR 28 crore to INR 31 crore.
Outlook and guidance
Guidance maintained for high single-digit growth and EBITDA margin expansion of about 1.5%.
Confident of margin improvement with better capacity utilization; H2 expected to be significantly better.
Q2 already showing improvement, with sanitaryware back to full capacity and Max plant expected to recover in another quarter.
Strategic focus on project sales and retail footprint to capitalize on recovery opportunities.
Investment in new subsidiary to address future cash flow requirements and capital expenditure.
Latest events from Somany Ceramics
- Margin expansion and growth driven by premiumization, capacity upgrades, and bathware focus.531548
Investor presentation - Flat Q1 sales and margins, but double-digit growth targeted as demand recovers in H2.531548
Q1 24/25 - Q2 FY25 sales rose 1.4% to INR 662 crores, but PAT fell 41.2% amid muted demand.531548
Q2 24/25 - Q3 FY25 sales rose up to 5.1%, but profit fell on margin pressure and strategic divestments.531548
Q3 24/25 - Q4 FY25 delivered 5% sales growth, margin resilience, and strategic expansion despite profit decline.531548
Q4 24/25 - Q2 revenue up 3.6% YoY, consolidated PAT down 29%, margin improvement and synergies targeted.531548
Q2 25/26 - Q3 revenue rose 6% with margin gains, higher PAT, and new HR and Labour Code provisions.531548
Q3 25/26 - FY26 saw margin expansion, strong cash flow, and strategic investment despite input cost risks.531548
Q4 25/26 - Q1 FY27 revenue up 24% YoY, EBITDA margin at 11.6%, PAT up 365.7%, outlook positive.531548
Q1 26/27